ATE411044T1 - Monozyte-spezifisches teilchenförmiges verabreichungsvehikel - Google Patents

Monozyte-spezifisches teilchenförmiges verabreichungsvehikel

Info

Publication number
ATE411044T1
ATE411044T1 AT02723679T AT02723679T ATE411044T1 AT E411044 T1 ATE411044 T1 AT E411044T1 AT 02723679 T AT02723679 T AT 02723679T AT 02723679 T AT02723679 T AT 02723679T AT E411044 T1 ATE411044 T1 AT E411044T1
Authority
AT
Austria
Prior art keywords
vector
applications
administration vehicle
monocytic
inventive
Prior art date
Application number
AT02723679T
Other languages
English (en)
Inventor
Thomas Wagner
Xianzhong Yu
Original Assignee
Ghc Res Dev Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghc Res Dev Corp filed Critical Ghc Res Dev Corp
Application granted granted Critical
Publication of ATE411044T1 publication Critical patent/ATE411044T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT02723679T 2001-03-30 2002-04-01 Monozyte-spezifisches teilchenförmiges verabreichungsvehikel ATE411044T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27976901P 2001-03-30 2001-03-30

Publications (1)

Publication Number Publication Date
ATE411044T1 true ATE411044T1 (de) 2008-10-15

Family

ID=23070360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02723679T ATE411044T1 (de) 2001-03-30 2002-04-01 Monozyte-spezifisches teilchenförmiges verabreichungsvehikel

Country Status (9)

Country Link
US (1) US6875612B2 (de)
EP (1) EP1372704B1 (de)
JP (2) JP4430868B2 (de)
CN (2) CN1512894B (de)
AT (1) ATE411044T1 (de)
CA (1) CA2442682C (de)
DE (1) DE60229363D1 (de)
ES (1) ES2318002T3 (de)
WO (1) WO2002078733A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200502391A (en) * 2003-05-08 2005-01-16 Xcyte Therapies Inc Generation and isolation of antigen-specific t cells
JP2010524507A (ja) * 2007-04-25 2010-07-22 オービス・ヘルス・ソリューションズ マクロファージ・トランスフェクション法
US20100111985A1 (en) * 2007-04-25 2010-05-06 Orbis Health Solutions, Llc Vaccine compositions and methods of use
US20090081789A1 (en) * 2007-08-31 2009-03-26 Greenville Hospital System Activation of nuclear factor kappa B
EP2638896A1 (de) 2012-03-14 2013-09-18 Bioneer A/S Kationisches liposomales Arzneimittelabgabesystem für spezifisches Targeting humaner CD14+ Monozyten in Vollblut
WO2014078768A1 (en) * 2012-11-19 2014-05-22 Troyer Deryl L Leukocytes as delivery cells for imaging and disease therapy
US10801041B2 (en) * 2015-11-18 2020-10-13 Orbis Health Solutions, Llc T7 alpha viral vector system
US20190365657A1 (en) * 2016-08-17 2019-12-05 Orbis Health Solutions, Llc Tumor-targeting bead vectors and methods of using the same
CN114555191A (zh) * 2019-05-29 2022-05-27 奥比思健康解决方案有限责任公司 用于表达嵌合受体的递送载体和颗粒及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL103059A0 (en) * 1991-09-30 1993-02-21 Boehringer Ingelheim Int Conjugates for introducing nucleic acid into higher eucaryotic cells
TR199800573T2 (xx) * 1995-09-28 1998-07-21 University Of Pittsburgh-Commonwealth System Of Higher Edu. Hedeflenen partik�lat genetik immunizasyonu sureti ile h�cre medyasyonlu immun cevaplar�n stim�lasyonu.
US6630169B1 (en) * 1999-03-31 2003-10-07 Nektar Therapeutics Particulate delivery systems and methods of use
AU4544600A (en) * 1999-04-06 2000-10-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Pharmaceutical compositions comprising circulating blood cells, preferably monocytes and uses thereof
US20020006412A1 (en) * 2000-04-28 2002-01-17 Roberts Bruce L. Preparation and use of particulates composed of adenovirus particles

Also Published As

Publication number Publication date
WO2002078733A1 (en) 2002-10-10
US6875612B2 (en) 2005-04-05
EP1372704A1 (de) 2004-01-02
CA2442682C (en) 2011-08-02
DE60229363D1 (de) 2008-11-27
EP1372704B1 (de) 2008-10-15
JP2010031020A (ja) 2010-02-12
JP2005508843A (ja) 2005-04-07
CN1512894B (zh) 2010-06-16
CN1512894A (zh) 2004-07-14
JP4430868B2 (ja) 2010-03-10
US20020155609A1 (en) 2002-10-24
ES2318002T3 (es) 2009-05-01
CA2442682A1 (en) 2002-10-10
CN101897983A (zh) 2010-12-01

Similar Documents

Publication Publication Date Title
Chen et al. Arginine signaling and cancer metabolism
Zhao et al. An injectable hydrogel reshaping adenosinergic axis for cancer therapy
Chen et al. Improved antigen cross-presentation by polyethyleneimine-based nanoparticles
EP1335661A4 (de) Herstellung von mikrokügelchen
WO2010129023A3 (en) Supercharged proteins for cell penetration
ATE411044T1 (de) Monozyte-spezifisches teilchenförmiges verabreichungsvehikel
CY1112110T1 (el) Κυκλικο μοριο dna το οποιο διαθετει μια συμβατικη αφετηρια αντιγραφης, η διαδικασια παρασκευης του και η χρηση του στην γονιδιακη θεραπεια
PL350658A1 (en) Medical preparations for the treatment of alpha−galactosidase a deficiency
IL171966A0 (en) Prostate stem cell antigen variants and pharmaceutical compositions based thereon
WO2004074450A8 (en) Combination therapy for treating protein deficiencies
WO2006073748A3 (en) Antibodies against antigen presenting cells and uses thereof
WO2001023421A3 (en) Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
WO2008127285A3 (en) Target peptides for ovarian cancer immunotherapy
IL178042A0 (en) Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation
CY1113064T1 (el) Νουκλεϊνικο οξυ και αντιστοιχη πρωτεϊνη με τιτλο 184ρ1ε2 χρησιμα στη θεραπεια και ανιχνευση καρκινου
EP1708752A4 (de) Therapeutisches krebsmittel mit polymergebundenem antikörper
IL181218A0 (en) Nucleic acids and corresponding 58p1d12 proteins for use in the detection and treatment of cancer
MXPA02007899A (es) Citoquinas modificadas para utilizarse en terapia de cancer.
SI1530628T1 (sl) Postopek za proizvodnjo s temperaturo induciranih lizatov tumorskih celic za uporabo kot imunogenske spojine
WO2003082330A1 (en) Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles
WO2003060066A3 (en) Nucleic acid delivery and expression
WO2004009112A8 (en) Use of urease for inhibiting cancer cell growth
WO2005118864A3 (en) Antibodies and related molecules that bind to psca proteins
TR200501460T3 (tr) Onkolitik virüsler kullanarak ağrı azaltma yöntemi
ATE412763T1 (de) Antikörper-abhängige vergrösserung der alphavirus-infektvität

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties